96 related articles for article (PubMed ID: 20118197)
1. Artemin stimulates oncogenicity and invasiveness of human endometrial carcinoma cells.
Pandey V; Qian PX; Kang J; Perry JK; Mitchell MD; Yin Z; Wu ZS; Liu DX; Zhu T; Lobie PE
Endocrinology; 2010 Mar; 151(3):909-20. PubMed ID: 20118197
[TBL] [Abstract][Full Text] [Related]
2. Artemin-stimulated progression of human non-small cell lung carcinoma is mediated by BCL2.
Tang JZ; Kong XJ; Kang J; Fielder GC; Steiner M; Perry JK; Wu ZS; Yin Z; Zhu T; Liu DX; Lobie PE
Mol Cancer Ther; 2010 Jun; 9(6):1697-708. PubMed ID: 20530713
[TBL] [Abstract][Full Text] [Related]
3. Artemin is oncogenic for human mammary carcinoma cells.
Kang J; Perry JK; Pandey V; Fielder GC; Mei B; Qian PX; Wu ZS; Zhu T; Liu DX; Lobie PE
Oncogene; 2009 May; 28(19):2034-45. PubMed ID: 19363524
[TBL] [Abstract][Full Text] [Related]
4. ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma.
Banerjee A; Wu ZS; Qian P; Kang J; Pandey V; Liu DX; Zhu T; Lobie PE
Breast Cancer Res; 2011; 13(6):R112. PubMed ID: 22060274
[TBL] [Abstract][Full Text] [Related]
5. Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma.
Kang J; Qian PX; Pandey V; Perry JK; Miller LD; Liu ET; Zhu T; Liu DX; Lobie PE
Oncogene; 2010 Jun; 29(22):3228-40. PubMed ID: 20305694
[TBL] [Abstract][Full Text] [Related]
6. Expression and clinical significance of ARTN and MMP-9 in endometrial carcinoma.
Wang XH; Liu YN; Tian K; Yao CX; Li LM; Zheng YQ; Shi ZM
J Biol Regul Homeost Agents; 2017; 31(4):879-887. PubMed ID: 29254290
[TBL] [Abstract][Full Text] [Related]
7. Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma.
Zhang M; Zhang W; Wu Z; Liu S; Sun L; Zhong Y; Zhang X; Kong X; Qian P; Zhang H; Lobie PE; Zhu T
Oncotarget; 2016 Jan; 7(3):3267-82. PubMed ID: 26675549
[TBL] [Abstract][Full Text] [Related]
8. Artemin Reduces Sensitivity to Doxorubicin and Paclitaxel in Endometrial Carcinoma Cells through Specific Regulation of CD24.
Pandey V; Jung Y; Kang J; Steiner M; Qian PX; Banerjee A; Mitchell MD; Wu ZS; Zhu T; Liu DX; Lobie PE
Transl Oncol; 2010 Aug; 3(4):218-29. PubMed ID: 20689763
[TBL] [Abstract][Full Text] [Related]
9. Autocrine Prolactin Stimulates Endometrial Carcinoma Growth and Metastasis and Reduces Sensitivity to Chemotherapy.
Ding K; Yuan Y; Chong QY; Yang Y; Li R; Li X; Kong X; Qian P; Xiong Z; Pandey V; Ma L; Wu Z; Lobie PE; Zhu T
Endocrinology; 2017 Jun; 158(6):1595-1611. PubMed ID: 28204229
[TBL] [Abstract][Full Text] [Related]
10. STAT3alpha is oncogenic for endometrial carcinoma cells and mediates the oncogenic effects of autocrine human growth hormone.
Tang JZ; Kong XJ; Banerjee A; Muniraj N; Pandey V; Steiner M; Perry JK; Zhu T; Liu DX; Lobie PE
Endocrinology; 2010 Sep; 151(9):4133-45. PubMed ID: 20668024
[TBL] [Abstract][Full Text] [Related]
11. miR-223 regulates migration and invasion by targeting Artemin in human esophageal carcinoma.
Li S; Li Z; Guo F; Qin X; Liu B; Lei Z; Song Z; Sun L; Zhang HT; You J; Zhou Q
J Biomed Sci; 2011 Mar; 18(1):24. PubMed ID: 21453483
[TBL] [Abstract][Full Text] [Related]
12. Trefoil factor-1 (TFF1) enhances oncogenicity of mammary carcinoma cells.
Amiry N; Kong X; Muniraj N; Kannan N; Grandison PM; Lin J; Yang Y; Vouyovitch CM; Borges S; Perry JK; Mertani HC; Zhu T; Liu D; Lobie PE
Endocrinology; 2009 Oct; 150(10):4473-83. PubMed ID: 19589871
[TBL] [Abstract][Full Text] [Related]
13. Enolase-1 is a therapeutic target in endometrial carcinoma.
Zhao M; Fang W; Wang Y; Guo S; Shu L; Wang L; Chen Y; Fu Q; Liu Y; Hua S; Fan Y; Liu Y; Deng X; Luo R; Mei Z; Jiang Q; Liu Z
Oncotarget; 2015 Jun; 6(17):15610-27. PubMed ID: 25951350
[TBL] [Abstract][Full Text] [Related]
14. ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling.
Banerjee A; Wu ZS; Qian PX; Kang J; Liu DX; Zhu T; Lobie PE
PLoS One; 2012; 7(11):e50098. PubMed ID: 23185544
[TBL] [Abstract][Full Text] [Related]
15. Silencing of Cathepsin B suppresses the proliferation and invasion of endometrial cancer.
Bao W; Fan Q; Luo X; Cheng WW; Wang YD; Li ZN; Chen XL; Wu D
Oncol Rep; 2013 Aug; 30(2):723-30. PubMed ID: 23708264
[TBL] [Abstract][Full Text] [Related]
16. Artemin stimulates radio- and chemo-resistance by promoting TWIST1-BCL-2-dependent cancer stem cell-like behavior in mammary carcinoma cells.
Banerjee A; Qian P; Wu ZS; Ren X; Steiner M; Bougen NM; Liu S; Liu DX; Zhu T; Lobie PE
J Biol Chem; 2012 Dec; 287(51):42502-15. PubMed ID: 23095743
[TBL] [Abstract][Full Text] [Related]
17. ARTEMIN Promotes Oncogenicity and Resistance to 5-Fluorouracil in Colorectal Carcinoma by p44/42 MAPK Dependent Expression of CDH2.
Zhuang QS; Sun XB; Chong QY; Banerjee A; Zhang M; Wu ZS; Zhu T; Pandey V; Lobie PE
Front Oncol; 2021; 11():712348. PubMed ID: 34422665
[TBL] [Abstract][Full Text] [Related]
18. Artemin promotes oncogenicity, metastasis and drug resistance in cancer cells.
Hezam K; Jiang J; Sun F; Zhang X; Zhang J
Rev Neurosci; 2018 Jan; 29(1):93-98. PubMed ID: 28937965
[TBL] [Abstract][Full Text] [Related]
19. Hypomethylation associated enhanced transcription of trefoil factor-3 mediates tamoxifen-stimulated oncogenicity of ER+ endometrial carcinoma cells.
Pandey V; Zhang M; Chong QY; You M; Raquib AR; Pandey AK; Liu DX; Liu L; Ma L; Jha S; Wu ZS; Zhu T; Lobie PE
Oncotarget; 2017 Sep; 8(44):77268-77291. PubMed ID: 29100386
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C alpha (PKCalpha) regulates growth and invasion of endometrial cancer cells.
Haughian JM; Bradford AP
J Cell Physiol; 2009 Jul; 220(1):112-8. PubMed ID: 19235902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
